EY
NASDAQ · EYES
Second Sight Medical Products, Inc.
Healthcare · Medical - Devices
$28.49
Down-$0.28 (-0.97%)
Updated Sep 16, 2026, 10:55 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 210.05M
- P/E ratio
- -0.32
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 349.1
- Avg. volume
- 76.72K
Price performance
EYES price history
1M range · 20 trading sessions · Daily adjusted prices
EYES closed at $28.49 after 20 trading sessions, down 4.05% for the selected period.
- Last close
- $28.49
- Period change
- -4.05%
- Period low
- $27.87
- Period high
- $30.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $28.28 | $28.551 | $28.28 | $28.4867 | 349.1 |
| Sep 14, 2026 | $28.44 | $28.8264 | $28.435 | $28.7667 | 545.64 |
| Sep 11, 2026 | $27.97 | $27.97 | $27.91 | $27.9365 | 558.34 |
| Sep 10, 2026 | $28.11 | $28.11 | $27.8707 | $27.8707 | 967 |
| Sep 9, 2026 | $28.05 | $28.0634 | $28.0202 | $28.0202 | 464.84 |
| Sep 8, 2026 | $28.2837 | $28.2837 | $28.2837 | $28.2837 | 158.91 |
| Sep 4, 2026 | $28.865 | $28.865 | $28.73 | $28.7322 | 711.81 |
| Sep 3, 2026 | $29.2433 | $29.2433 | $29.2433 | $29.2433 | 61.17 |
| Sep 2, 2026 | $28.63 | $28.63 | $28.5091 | $28.5091 | 549.96 |
| Sep 1, 2026 | $29.135 | $29.22 | $29.0889 | $29.0889 | 1.01K |
| Aug 31, 2026 | $29.964 | $29.964 | $29.964 | $29.964 | 232.35 |
| Aug 28, 2026 | $30.10 | $30.10 | $30.10 | $30.10 | 356.24 |
| Aug 27, 2026 | $30.18 | $30.18 | $30.13 | $30.13 | 452.24 |
| Aug 26, 2026 | $29.2901 | $29.2901 | $29.2901 | $29.2901 | 198.31 |
| Aug 25, 2026 | $29.17 | $29.17 | $29.0582 | $29.0582 | 214.41 |
| Aug 24, 2026 | $29.75 | $29.75 | $29.2642 | $29.2642 | 907.74 |
| Aug 21, 2026 | $29.722 | $29.722 | $29.722 | $29.722 | 120.21 |
| Aug 20, 2026 | $29.57 | $29.57 | $29.3298 | $29.3298 | 757.14 |
| Aug 19, 2026 | $29.9401 | $29.9401 | $29.7952 | $29.7952 | 836.41 |
| Aug 18, 2026 | $28.71 | $29.69 | $28.71 | $29.69 | 1.49K |
Latest EYES news
The latest Smart Investors Daily articles mentioning EYES.
Stock researchCompany · Financials
Loading stock research…
